Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz

Obere Zahlbacher Str. 63, Geb. 912, 55131 Mainz
  • 06131/17-9704 oder 9799 (Sekretariat)
  • 06131/17-9669
Publikationen
Ergebnisse pro Seite:  10


Yesilyurt, ZE; Ertürk, BM; Erdogan, BR et al.

Effects of the sodium-glucose transporter 2 inhibitor empagliflozin on bladder size, contraction and relaxation in a rat model of type 1 diabetes

Neurourol. Urodyn. Bd. 40 Suppl. 2. 2021 S. 141-142


Boon, Gudula J. A. M.; Janssen, Steffi M. J.; Barco, Stefano et al.

Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome

THROMBOSIS RESEARCH. Bd. 206. 2021 S. 66-75


Rudnicka, Lidia; Olszewska, Malgorzata; Goldust, Mohamad et al.

Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment

JOURNAL OF CLINICAL MEDICINE. Bd. 10. H. 23. 2021


Klok, F. A.; Toenges, G.; Barco, S. et al.

Efficacy and safety of early switch to oral anticoagulation in acute intermediate-risk pulmonary embolism

EUROPEAN HEART JOURNAL. Bd. 42. 2021 S. 1923-1923



Retz, W

Efficacy of amphetamines, methylphenidate, and modfinil in the treatment of mental disorders

Riederer P, Laux G, Nagatsu T, Le W, Riederer C (Hrsg). NeuroPsychopharmacotherapy. Springer Nature Switzerland 2021


Reinisch, Mattea; Seiler, Sabine; Hauzenberger, Tanja et al.

Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men Results from the MALE Phase 2 Randomized Clinical Trial

JAMA ONCOLOGY. Bd. 7. H. 4. 2021 S. 565-572


Saalfeld, Felix C.; Wenzel, Carina; Christopoulos, Petros et al.

Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations

JOURNAL OF THORACIC ONCOLOGY. Bd. 16. H. 11. 2021 S. 1952-1958


Dietz, Julia; Spengler, Ulrich; Mullhaupt, Beat et al.

Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. Bd. 19. H. 1. 2021 S. 195-+